Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in CDXS — Codexis, Inc.

CIK 916542 Boston, MA
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$809,724
+$608,014 QoQ
Shares Held
358,285
+189.5% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 148 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. CDXS ranks #73 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in CDXS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $809,724 358,285
2026-03-31 $201,710 123,749
2025-12-31 $144,052 88,376
2025-09-30 $147,290 60,365
2025-06-30 $200,170 82,037
2025-03-31 $1,063,179 395,234
2024-12-31 $2,307,401 483,732
2024-09-30 $2,279,621 740,137
2024-06-30 $2,075,831 669,623
2024-03-31 $2,719,879 779,335
2023-12-31 $2,385,548 782,147
2023-09-30 $1,795,341 949,916
2023-06-30 $2,114,050 755,018
2023-03-31 $799,968 193,229
2022-12-31 $489,346 105,010
2022-09-30 $70,665 11,661
2022-06-30 $148,375 14,185